IVD Medical Holding Limited (HKG:1931)
Hong Kong · Delayed Price · Currency is HKD 8.72
+0.08 (0.93%)
Aug 15, 2025, 4:08 PM HKT
IVD Medical Holding Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| 3,162 | 3,088 | 2,749 | 2,731 | 2,428 | Upgrade | |
Revenue Growth (YoY) | 2.40% | 12.35% | 0.66% | 12.46% | 4.09% | Upgrade |
Cost of Revenue | 2,411 | 2,417 | 2,141 | 2,164 | 1,952 | Upgrade |
Gross Profit | 751.17 | 671.7 | 608.14 | 566.27 | 476.17 | Upgrade |
Selling, General & Admin | 305.14 | 296.29 | 270.45 | 306.42 | 249.77 | Upgrade |
Operating Expenses | 306.93 | 295.34 | 273.14 | 307.22 | 249.1 | Upgrade |
Operating Income | 444.24 | 376.37 | 335 | 259.05 | 227.06 | Upgrade |
Interest Expense | -35.98 | -21.04 | -30.58 | -20.42 | -23.75 | Upgrade |
Interest & Investment Income | 2.67 | 2.91 | 1.97 | 1.76 | 2.1 | Upgrade |
Earnings From Equity Investments | -18.83 | -22.66 | 2.8 | 8.34 | 0.58 | Upgrade |
Currency Exchange Gain (Loss) | 1.79 | 9.2 | -10.34 | 3.64 | -2 | Upgrade |
Other Non Operating Income (Expenses) | 17.37 | 16.87 | 16.47 | 18.19 | 24.31 | Upgrade |
EBT Excluding Unusual Items | 411.26 | 361.65 | 315.32 | 270.55 | 228.31 | Upgrade |
Gain (Loss) on Sale of Investments | -9.47 | -20.63 | -11.46 | 11.85 | 4.54 | Upgrade |
Gain (Loss) on Sale of Assets | 0.05 | -1.7 | -0.01 | 0.09 | -0.9 | Upgrade |
Asset Writedown | - | - | -20.44 | -14.56 | - | Upgrade |
Other Unusual Items | -0.07 | 0.01 | 0.38 | 0.01 | - | Upgrade |
Pretax Income | 401.78 | 339.33 | 283.79 | 267.94 | 231.96 | Upgrade |
Income Tax Expense | 135.74 | 102.2 | 88.26 | 106.19 | 77.34 | Upgrade |
Earnings From Continuing Operations | 266.03 | 237.13 | 195.53 | 161.75 | 154.62 | Upgrade |
Minority Interest in Earnings | -5.61 | 1.04 | 14.47 | 12.79 | 4.1 | Upgrade |
Net Income | 260.42 | 238.16 | 210 | 174.54 | 158.72 | Upgrade |
Net Income to Common | 260.42 | 238.16 | 210 | 174.54 | 158.72 | Upgrade |
Net Income Growth | 9.35% | 13.41% | 20.32% | 9.97% | -42.29% | Upgrade |
Shares Outstanding (Basic) | 1,495 | 1,352 | 1,345 | 1,323 | 1,330 | Upgrade |
Shares Outstanding (Diluted) | 1,495 | 1,352 | 1,355 | 1,349 | 1,339 | Upgrade |
Shares Change (YoY) | 10.60% | -0.23% | 0.42% | 0.80% | 17.42% | Upgrade |
EPS (Basic) | 0.17 | 0.18 | 0.16 | 0.13 | 0.12 | Upgrade |
EPS (Diluted) | 0.17 | 0.18 | 0.15 | 0.13 | 0.12 | Upgrade |
EPS Growth | -1.14% | 13.66% | 19.79% | 9.11% | -44.80% | Upgrade |
Free Cash Flow | 88.69 | 251.92 | 215.39 | 137.88 | 144.87 | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.19 | 0.16 | 0.10 | 0.11 | Upgrade |
Dividend Per Share | - | 0.083 | 0.073 | 0.065 | 0.044 | Upgrade |
Dividend Growth | - | 13.69% | 13.24% | 45.59% | -7.33% | Upgrade |
Gross Margin | 23.75% | 21.75% | 22.12% | 20.74% | 19.61% | Upgrade |
Operating Margin | 14.05% | 12.19% | 12.19% | 9.49% | 9.35% | Upgrade |
Profit Margin | 8.24% | 7.71% | 7.64% | 6.39% | 6.54% | Upgrade |
Free Cash Flow Margin | 2.80% | 8.16% | 7.84% | 5.05% | 5.97% | Upgrade |
EBITDA | 467.15 | 400.33 | 357.54 | 286.17 | 250.05 | Upgrade |
EBITDA Margin | 14.77% | 12.96% | 13.01% | 10.48% | 10.30% | Upgrade |
D&A For EBITDA | 22.91 | 23.97 | 22.54 | 27.12 | 22.98 | Upgrade |
EBIT | 444.24 | 376.37 | 335 | 259.05 | 227.06 | Upgrade |
EBIT Margin | 14.05% | 12.19% | 12.19% | 9.49% | 9.35% | Upgrade |
Effective Tax Rate | 33.79% | 30.12% | 31.10% | 39.63% | 33.34% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.